Sarcopenia in a mice model of chronic liver disease: role of the ubiquitin–proteasome system and oxidative stress

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pflügers Archiv: European Journal of Physiology

• Publication date

  2018-06-20

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s00424-018-2167-3PMID 29926227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of long-term exposures to low iron and branched-chain amino acid containing diets on aging skeletal muscle of Fisher 344 × Brown Norway rats.

  2018cited by this paper
• Hyperammonemia and proteostasis in cirrhosis

  2018cited by this paper
• Myostatin and beyond in cirrhosis: all roads lead to sarcopenia

  2017cited by this paper
• Sarcopenia in Patients with Advanced Liver Disease.

  2017cited by this paper
• Role of PARP activity in lung cancer‐induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype

  2017cited by this paper
• Exercise and physical activity for patients with end‐stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list

  2017cited by this paper
• The complex of PAMAM-OH dendrimer with Angiotensin (1–7) prevented the disuse-induced skeletal muscle atrophy in mice

  2017cited by this paper
• Skeletal muscle wasting: new role of nonclassical renin–angiotensin system

  2017cited by this paper
• A multicenter study to define sarcopenia in patients with end‐stage liver disease

  2017cited by this paper
• The physiopathologic role of oxidative stress in skeletal muscle.

  2017cited by this paper
• Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume

  2017cited by this paper
• The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)

  2017cited by this paper
• Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy

  2016cited by this paper
• Redox control of skeletal muscle atrophy.

  2016cited by this paper
• A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study

  2016cited by this paper
• Cytokine Signaling in Skeletal Muscle Wasting.

  2016cited by this paper
• Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes

  2016cited by this paper
• Review article: sarcopenia in cirrhosis – aetiology, implications and potential therapeutic interventions

  2016cited by this paper
• The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass.

  2016cited by this paper
• High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis

  2016cited by this paper
• Role of Protein Carbonylation in Skeletal Muscle Mass Loss Associated with Chronic Conditions

  2016cited by this paper
• Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6

  2016cited by this paper
• Transforming growth factor type beta (TGF-β) requires reactive oxygen species to induce skeletal muscle atrophy.

  2016cited by this paper
• The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation.

  2016cited by this paper
• Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1

  2016cited by this paper
• Angiotensin-(1-7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF-β) via Mas Receptor Activation

  2016cited by this paper
• Bile acids as metabolic regulators

  2015cited by this paper
• Prediction of Esophageal Variceal Bleeding in Liver Cirrhosis: Is There a Role for Hemostatic Factors?

  2015cited by this paper
• Expression of ammonia transporters Rhbg and Rhcg in mouse skeletal muscle and the effect of 6-week training on these proteins

  2015cited by this paper
• Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.

  2015cited by this paper
• The Cholangiopathies.

  2015cited by this paper
• Peroxynitrite induces degradation of myosin heavy chain via p38 MAPK and muscle-specific E3 ubiquitin ligases in C2 skeletal myotubes.

  2015cited by this paper
• Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies

  2014cited by this paper
• The angiotensin-(1–7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice

  2014cited by this paper
• Rats Fed Diets with Different Energy Contribution from Fat Do Not Differ in Adiposity

  2014cited by this paper
• Nutrition and exercise in the management of liver cirrhosis.

  2014cited by this paper
• Treatment to Improve Nutrition and Functional Capacity Evaluation in Liver Transplant Candidates

  2014cited by this paper
• Early changes in muscle atrophy and muscle fiber type conversion after spinal cord transection and peripheral nerve transection in rats

  2013cited by this paper
• Cellular and molecular mechanisms of muscle atrophy

  2013cited by this paper
• Bile acid metabolism and signaling.

  2013cited by this paper
• Measuring the Strength of Mice

  2013cited by this paper
• Interleukin‐6 myokine signaling in skeletal muscle: a double‐edged sword?

  2013cited by this paper
• Experimental liver fibrosis research: update on animal models, legal issues and translational aspects

  2013cited by this paper
• Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007–2011

  2013cited by this paper
• Transition between Acute and Chronic Hepatotoxicity in Mice Is Associated with Impaired Energy Metabolism and Induction of Mitochondrial Heme Oxygenase-1

  2013cited by this paper
• Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB–mediated mechanism

  2013cited by this paper
• Assessing portal hypertension in liver diseases

  2013cited by this paper
• Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2)

  2013cited by this paper
• Exercise Training Prevents Oxidative Stress and Ubiquitin-Proteasome System Overactivity and Reverse Skeletal Muscle Atrophy in Heart Failure

  2012cited by this paper
• Does oxidative stress modulate limb muscle atrophy in severe COPD patients?

  2012cited by this paper
• Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles

  2012cited by this paper
• Consilience in sarcopenia of cirrhosis

  2012cited by this paper
• Rapid Determination of Myosin Heavy Chain Expression in Rat, Mouse, and Human Skeletal Muscle Using Multicolor Immunofluorescence Analysis

  2012cited by this paper
• Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis.

  2012cited by this paper
• Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value

  2012cited by this paper
• Muscle wasting is associated with mortality in patients with cirrhosis.

  2012cited by this paper
• Myostatin: a novel insight into its role in metabolism, signal pathways, and expression regulation.

  2011cited by this paper
• CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy

  2011cited by this paper
• Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contraction-induced hepatokine.

  2011cited by this paper
• Liver transplantation results for hepatocellular carcinoma in Chile.

  2010cited by this paper
• Tumor Necrosis Factor-α Regulates Distinct Molecular Pathways and Gene Networks in Cultured Skeletal Muscle Cells

  2010cited by this paper
• The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice

  2010cited by this paper
• Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis

  2010cited by this paper
• Reversible and irreversible modifications of skeletal muscle proteins in a rat model of acute oxidative stress.

  2009cited by this paper
• Reactive oxygen species are signalling molecules for skeletal muscle adaptation

  2009cited by this paper
• Assessment of Prognosis of Cirrhosis

  2008cited by this paper
• Human skeletal muscle aging and the oxidative system: cellular events.

  2008cited by this paper
• Muscle wasting in diabetic and in tumor-bearing rats: role of oxidative stress.

  2008cited by this paper
• Oxidative stress and disuse muscle atrophy.

  2007cited by this paper
• A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.

  2007cited by this paper
• Caspase-3 regulation of diaphragm myonuclear domain during mechanical ventilation-induced atrophy.

  2007cited by this paper
• Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

  2006cited by this paper
• Mechanisms of disuse muscle atrophy: role of oxidative stress.

  2005cited by this paper
• IL-6-induced skeletal muscle atrophy.

  2005cited by this paper
• Novel aspects on the regulation of muscle wasting in sepsis.

  2005cited by this paper
• Proinflammatory cytokines and skeletal muscle

  2004cited by this paper
• Food Intake, Water Intake, and Drinking Spout Side Preference of 28 Mouse Strains

  2002cited by this paper
• Cytokines and liver diseases.

  2001cited by this paper
• Myosin isoforms, muscle fiber types, and transitions

  2000cited by this paper
• Serum levels of cytokines in chronic liver diseases.

  1992cited by this paper

• The Inflammation-Energy Metabolism Axis: A Central Driver of Sarcopenia-Osteoporosis: A Narrative Review

  2026cites this paper
• Sarcopenia modelling by portal vein ligation inducing hyperammonemia in rats

  2025cites this paper
• The Effects of Flaxseed Consumption on Frailty and Sarcopenia in Patients With Liver Cirrhosis: An Open‐Labeled Randomized Controlled Clinical Trial

  2025cites this paper
• Proteasome-driven modulation of immune and oxidative pathways during scorpion envenomation pathogenesis

  2025cites this paper
• Gardenia Fruit and Its Active Compound Crocin Protect Against Dexamethasone‐Induced Muscle Atrophy via Nrf2 Activation

  2025cites this paper
• Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review

  2025cites this paper
• Exploration of Pathogenesis and Cutting-Edge Treatment Strategies of Sarcopenia: A Narrative Review

  2025cites this paper
• The role of chronic low-grade inflammation in the development of sarcopenia: Advances in molecular mechanisms.

  2025cites this paper
• CCL5 Induces a Sarcopenic-like Phenotype via the CCR5 Receptor

  2025cites this paper
• Blockade of forkhead box protein O1 signaling alleviates primary sclerosing cholangitis-induced sarcopenia in mice model.

  2024cites this paper
• The role of bile acid metabolism in bone and muscle: from analytics to mechanisms

  2024cites this paper
• The Role of Sirtuins in Sarcopenia and Frailty

  2023cites this paper
• Bile acids as signaling molecules: Role of ursodeoxycholic acid in cholestatic liver disease.

  2023cites this paper
• Skeletal Muscle Fibre Morphology in Childhood- Insights into Myopenia in Pediatric Liver Disease.

  2023cites this paper
• Cholic and deoxycholic acids induce mitochondrial dysfunction, impaired biogenesis and autophagic flux in skeletal muscle cells

  2023cites this paper
• Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice.

  2023cites this paper
• Ursodeoxycholic acid induces sarcopenia associated with decreased protein synthesis and autophagic flux

  2023cites this paper
• Differential Fibrotic Response of Muscle Fibroblasts, Myoblasts, and Myotubes to Cholic and Deoxycholic Acids.

  2023cites this paper
• Upregulation of CCL5/RANTES Gene Expression in the Diaphragm of Mice with Cholestatic Liver Disease.

  2023cites this paper
• Bile Acids Alter the Autophagy and Mitogenesis in Skeletal Muscle Cells.

  2023cites this paper
• Bile Acids Induce Alterations in Mitochondrial Function in Skeletal Muscle Fibers

  2022cites this paper
• Induction of Accelerated Aging in a Mouse Model

  2022cites this paper
• The Yucatan minipig model: A new preclinical model of malnutrition induced by a low-calorie/low-protein diet.

  2022cites this paper
• Potential Satellite Cell-Linked Biomarkers in Aging Skeletal Muscle Tissue: Proteomics and Proteogenomics to Monitor Sarcopenia

  2022cites this paper
• Angiotensin receptor blockers potentiate the protective effect of branched-chain amino acids on skeletal muscle atrophy in cirrhotic rats.

  2021cites this paper
• Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease

  2021cites this paper
• Redox-Dependent Effects in the Physiopathological Role of Bile Acids

  2021cites this paper
• Mouse models of sarcopenia: classification and evaluation

  2021cites this paper
• Sarcopenia Induced by Chronic Liver Disease in Mice Requires the Expression of the Bile Acids Membrane Receptor TGR5

  2020cites this paper
• Prevalence and temporal trends of presarcopenia metrics and related body composition measurements from the 1999 to 2006 NHANES

  2020cites this paper
• Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis

  2020cites this paper
• Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor

  2020cites this paper
• Protective Effect of Angiotensin 1–7 on Sarcopenia Induced by Chronic Liver Disease in Mice

  2020influential citation
• Dietary total antioxidant capacity is positively associated with muscular strength in cirrhotic outpatients: a cross-sectional study.

  2020cites this paper
• Angiotensin-(1-7) Prevents Lipopolysaccharide-Induced Autophagy via the Mas Receptor in Skeletal Muscle

  2020cites this paper
• (−)-Epicatechin reduces muscle waste after complete spinal cord transection in a murine model: role of ubiquitin–proteasome system

  2020cites this paper
• Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)

  2020cites this paper
• Prognostic Implications of Physical Frailty and Sarcopenia Pre and Post Transplantation

  2019cites this paper
• Insights into lipid accumulation in skeletal muscle in dysferlin-deficient mice[S]

  2019cites this paper
• N-Acetyl Cysteine attenuates the sarcopenia and muscle apoptosis induced by chronic liver disease.

  2019cites this paper
• Mitochondrial Dysfunction in Skeletal Muscle Pathologies.

  2019cites this paper